HealthASCIA Updates Risk-Based Guidance for Adult Penicillin-Allergy LabelsBy Naomi CalderOct 22, 2026, 12:05 AM UTC
BusinessAvivagen Reports Positive Proof of Concept in Preventing C. Difficile InfectionBy Nasdaq OMXApr 10, 2017, 11:43 AM UTC
BusinessFedora Pharmaceuticals Receives Support from the Government of Canada to Battle Antimicrobial Resistance with Novel Pipeline of Antibiotic CandidatesBy Nasdaq OMXJan 16, 2017, 3:51 PM UTC
